SingletO2 Therapeutics Competitors and Similar CompaniesClear all
SingletO2 Therapeutics's competitors and similar companies include CEL-SCI and Saniona.
 SingletO2 Therapeutics SingletO2 Therapeutics is a company engaged in developing treatments for periodontal disease. |  CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |  Saniona Saniona, a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. | |
Founding Date | Founding Date 2015 | Founding Date 1983 | Founding Date 2011 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Summit, US HQ | Locations Vienna, US HQ | Locations Ballerup, DK HQ Glostrup, DK Waltham, US |
Employees | Employees 2 | Employees N/A | Employees 22 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 58.7 m | Valuation ($) 42.9 m |
Financial | |||
Net income | Net income N/A | Net income ($25.4m) (FY, 2025) | Net income kr284.7m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
CEL-SCI
HQ
Vienna, US
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
View companySaniona
HQ
Ballerup, DK
Employees
22
Saniona, a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain.
View company